UBS Group’s SeaStar Medical Holding Corp Warrant ICUCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21 Buy
+717
New +$18 ﹤0.01% 10284
2025
Q4
Sell
-560
Closed -$15 10825
2025
Q3
$15 Sell
560
-248
-31% -$9 ﹤0.01% 10163
2025
Q2
$16 Buy
+808
New +$25 ﹤0.01% 10132
2024
Q2
Sell
-22,552
Closed -$3.29K 9765
2024
Q1
$3.29K Buy
22,552
+21,655
+2,414% +$2.57K ﹤0.01% 7751
2023
Q4
$27 Sell
897
-80
-8% -$3 ﹤0.01% 9052
2023
Q3
$14 Buy
+977
New +$26 ﹤0.01% 9174
2023
Q2
Sell
-5,079
Closed -$376 9221
2023
Q1
$376 Buy
5,079
+4,296
+549% +$471 ﹤0.01% 9057
2022
Q4
$70 Sell
783
-5,798
-88% -$578 ﹤0.01% 10444
2022
Q3
$0 Sell
6,581
-554
-8% -$46 ﹤0.01% 10600
2022
Q2
$1K Sell
7,135
-716
-9% -$104 ﹤0.01% 9882
2022
Q1
$2K Sell
7,851
-3,301
-30% -$878 ﹤0.01% 9637
2021
Q4
$5K Buy
11,152
+6,799
+156% +$3.39K ﹤0.01% 9396
2021
Q3
$2K Buy
4,353
+24
+0.6% +$12 ﹤0.01% 8960
2021
Q2
$2K Buy
+4,329
New +$1.8K ﹤0.01% 8949

Other funds holding ICUCW

UBS Group's ICUCW Position: Q1 2026 in Review

UBS Group opened a new position in SeaStar Medical Holding Corp Warrant (ICUCW) in Q1 2026: 717 shares worth $21. The stake represents ﹤0.01% of the portfolio and ranks #10284 among its holdings. This is a return to the name: UBS Group previously reported a position in ICUCW as recently as Q3 2025.

UBS Group first reported a position in ICUCW in Q2 2021 and has held it in 14 quarters since. The position peaked at $5K in Q4 2021. 10 funds tracked by Wall St. Rank hold ICUCW as of Q1 2026.

  • UBS Group held 717 shares of SeaStar Medical Holding Corp Warrant worth $21 as of Q1 2026.
  • SeaStar Medical Holding Corp Warrant was a new UBS Group position in Q1 2026.
  • SeaStar Medical Holding Corp Warrant made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10284 holding.
  • UBS Group first reported a position in SeaStar Medical Holding Corp Warrant in Q2 2021 and has held it in 14 quarters since.
  • UBS Group's SeaStar Medical Holding Corp Warrant position peaked at $5K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held SeaStar Medical Holding Corp Warrant as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.